Regenerx Biopharm In Performance

RGRXDelisted Stock  USD 0.0009  0.0001  12.50%   
The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and Regenerx Biopharm are completely uncorrelated. Regenerx Biopharm right now holds a risk of 0.0%. Please check Regenerx Biopharm accumulation distribution and relative strength index , to decide if Regenerx Biopharm will be following its historical price patterns.

Risk-Adjusted Performance

0 of 100

 
Low
 
High
Very Weak
Over the last 90 days Regenerx Biopharm In has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Regenerx Biopharm is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors. ...more
Begin Period Cash Flow427.9 K
  

Regenerx Biopharm Relative Risk vs. Return Landscape

If you would invest (100.00) in Regenerx Biopharm In on December 29, 2023 and sell it today you would earn a total of  100.00  from holding Regenerx Biopharm In or generate -100.0% return on investment over 90 days. Regenerx Biopharm In is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of otc stocks are less volatile than Regenerx, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  

Regenerx Biopharm Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Regenerx Biopharm's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Regenerx Biopharm In, and traders can use it to determine the average amount a Regenerx Biopharm's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
RGRX
Based on monthly moving average Regenerx Biopharm is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Regenerx Biopharm by adding Regenerx Biopharm to a well-diversified portfolio.

Regenerx Biopharm Fundamentals Growth

Regenerx OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Regenerx Biopharm, and Regenerx Biopharm fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Regenerx OTC Stock performance.

About Regenerx Biopharm Performance

To evaluate Regenerx Biopharm OTC Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Regenerx Biopharm generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Regenerx OTC Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Regenerx Biopharm market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Regenerx's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
RegeneRx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapeutic peptide, thymosin beta 4, for tissue and organ protection, repair, and regeneration. RegeneRx Biopharmaceuticals, Inc. was incorporated in 1982 and is based in Rockville, Maryland. REGENERX BIOPHARMACEUTICA operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 3 people.

Things to note about Regenerx Biopharm performance evaluation

Checking the ongoing alerts about Regenerx Biopharm for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Regenerx Biopharm help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Regenerx Biopharm is not yet fully synchronised with the market data
Regenerx Biopharm has some characteristics of a very speculative penny stock
Regenerx Biopharm has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 76.76 K. Net Loss for the year was (1.6 M) with profit before overhead, payroll, taxes, and interest of 70.12 K.
Regenerx Biopharm In currently holds about 478.41 K in cash with (990.3 K) of positive cash flow from operations.
Roughly 46.0% of the company outstanding shares are owned by corporate insiders
Evaluating Regenerx Biopharm's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Regenerx Biopharm's otc stock performance include:
  • Analyzing Regenerx Biopharm's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Regenerx Biopharm's stock is overvalued or undervalued compared to its peers.
  • Examining Regenerx Biopharm's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Regenerx Biopharm's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Regenerx Biopharm's management team can help you assess the OTC Stock's leadership.
  • Pay attention to analyst opinions and ratings of Regenerx Biopharm's otc stock. These opinions can provide insight into Regenerx Biopharm's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Regenerx Biopharm's otc stock performance is not an exact science, and many factors can impact Regenerx Biopharm's otc stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Consideration for investing in Regenerx OTC Stock

If you are still planning to invest in Regenerx Biopharm check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Regenerx Biopharm's history and understand the potential risks before investing.
Stocks Directory
Find actively traded stocks across global markets
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Content Syndication
Quickly integrate customizable finance content to your own investment portal
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios